⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Global Immunomodulators 2026-2031 - Rising Prevalence of Autoimmune Diseases Drives Market Growth
globenewswire.com
BMY
NVS
MRK
AMGN
PFE
LLY
BIIB
AZN
GILD
ABBV
TMO
REGN
IMUX
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Contact Levi & Korsinsky to Join Class Action Before September 14, 2026
accessnewswire.com
REGN
REGN Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regeneron Pharmaceuticals Securities Lawsuit - Contact Levi & Korsinsky
businesswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
prnewswire.com
REGN
Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. (REGN) Shareholders of Class Action Lawsuit and September 14, 2026 Deadline
accessnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. (REGN) Investors: September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit
prnewswire.com
REGN
REGENERNON PHARMACEUTICALS, INC. (REGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Deadline
globenewswire.com
REGN
Class Action Lawsuit Filed: Regeneron Pharmaceuticals, Inc. (REGN) - Join by September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN
Global LAG-3 Targeting Therapy Market Outlook Report 2031: Industry Size, Approved Therapy Dosage, Patent, Sales & Clinical Trials Insight
globenewswire.com
BMY
REGN
IMUX
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN